Watson Pharmaceuticals, Inc. and Sandoz, Inc. Pay $145 Million to Settle Pricing Case
Published: Sep 16, 2011
Watson Pharmaceuticals Inc., the generic-drug maker, will pay $79 million and Novartis AG’s Sandoz unit will pay $66 million to resolve claims they defrauded U.S. and state governments by causing Medicaid to overpay for drugs. Both lawsuits were filed under the U.S. False Claims Act by Ven-A-Care of the Florida Keys Inc., a specialty pharmacy. The settlements resolved portions of the U.S. false claims cases and similar claims by various states. The law allows whistle-blowers to file on behalf of the government and share in any recovery.